El Vínculo El Vínculo.
Closed European Union SuppliesFramework agreement

Kasvajavastased ja endokrinoloogilised ained (L01-L02)

Buyer: Aktsiaselts Ida-Tallinna Keskhaigla

Published
20 January 2025
Submission deadline
17 February 2025, 12:00
Estimated value
€12,398,000
Procedure
Open procedure
Documents
1
Notice number
00038044-2025
Reference
c62b35a7-675c-4fad-9660-592538d88caa
Official source
Official source

CPV codes

Description

Ravimite ostmine vastavalt RHAD lisas I Tehniline kirjeldus-pakkumuse vorm kirjeldatule.

Lots (39)

LotDescriptionCPV codeAmount
1 Tsüklofosfamiid
EE001
33600000 Productos farmacéuticos €16,000
2 Ifosfamiid
EE001
33600000 Productos farmacéuticos €5,000
3 Temosolomiid
EE001
33600000 Productos farmacéuticos €10,000
4 Metotreksaat
EE001
33600000 Productos farmacéuticos €5,000
5 Pemetrekseed
EE001
33600000 Productos farmacéuticos €6,000
6 Fluorouratsiil
EE001
33600000 Productos farmacéuticos €300,000
7 Gemtsitabiin
EE001
33600000 Productos farmacéuticos €85,000
8 Kapetsitabiin
EE001
33600000 Productos farmacéuticos €100,000
9 Vinorelbiin
EE001
33600000 Productos farmacéuticos €24,000
10 Etoposiid, infusioonilahuse kontsentraat, 100mg-200mg viaalis
EE001
33600000 Productos farmacéuticos €6,000
11 Etoposiid, pehmekapsel, 100mg
EE001
33600000 Productos farmacéuticos €10,000
12 Paklitakseel
EE001
33600000 Productos farmacéuticos €50,000
13 Dotsetakseel
EE001
33600000 Productos farmacéuticos €50,000
14 Doksorubitsiin
EE001
33600000 Productos farmacéuticos €25,000
15 Epirubitsiin
EE001
33600000 Productos farmacéuticos €70,000
16 Mitomütsiin
EE001
33600000 Productos farmacéuticos €14,000
17 Pertuzumab
EE001
33600000 Productos farmacéuticos €250,000
18 Trastuzumab-emtansiin
EE001
33600000 Productos farmacéuticos €1,200,000
19 Trastuzumab-derukstekaan
EE001
33600000 Productos farmacéuticos €800,000
20 Nivolumab, infusioonilahuse kontsentraat, 40mg/4ml
EE001
33600000 Productos farmacéuticos €12,000
21 Nivolumab, infusioonilahuse kontsentraat, 100mg/10ml
EE001
33600000 Productos farmacéuticos €80,000
22 Nivolumab, infusioonilahuse kontsentraat, 240mg/24ml
EE001
33600000 Productos farmacéuticos €1,300,000
23 Pembrolizumab
EE001
33600000 Productos farmacéuticos €3,200,000
24 Durvalumab
EE001
33600000 Productos farmacéuticos €380,000
25 Atesolizumab
EE001
33600000 Productos farmacéuticos €1,400,000
26 Dostarlimab
EE001
33600000 Productos farmacéuticos €180,000
27 Tsisplatiin
EE001
33600000 Productos farmacéuticos €18,000
28 Karboplatiin
EE001
33600000 Productos farmacéuticos €75,000
29 Oksaliplatiin
EE001
33600000 Productos farmacéuticos €150,000
30 Östramustiin
EE001
33600000 Productos farmacéuticos €8,000

Award criteria

Official publications

Other tenders from Aktsiaselts Ida-Tallinna Keskhaigla

Frequently asked questions

What is the deadline to bid for this tender?
The submission deadline is 17 February 2025, 12:00. Check the official source, as dates can be modified.
What is the estimated value of this tender?
The estimated value published by the buyer is €12,398,000.
Who is the buyer of this tender?
The contracting authority is Aktsiaselts Ida-Tallinna Keskhaigla (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.